Construction method of characteristic chromatogram of children pharyngeal flat granules containing in-vitro cultured calculus bovis as well as characteristic chromatogram and application of children pharyngeal flat granules
The characteristic map of pediatric pharyngeal flat particles was constructed through the combination of high-performance liquid chromatography-high resolution mass spectrometry, which solved the problem that existing detection methods could not reflect the overall components, and achieved rapid and efficient quality control of pediatric pharyngeal flat particles, ensuring that The safety and efficacy of the drug.
Patent Information
- Application Number
- CN202411193588.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-28
- Publication Date
- 2024-12-03
AI Technical Summary
The existing detection methods cannot effectively reflect the overall composition of pediatric pharyngeal flat particles, resulting in increased difficulty in quality control.
The combination of high-performance liquid chromatography-high resolution mass spectrometry was used to construct the characteristic map of pediatric pharyngeal flat particles containing beef yellow in vitro. The reference samples such as ejaculation, gurumbin, and cryptochlorogenic acid were combined with high-performance liquid chromatography and high-resolution Mass spectrometry technology determines the chemical composition of each peak in the characteristic map.
The simultaneous detection of multiple medicinal materials and multiple medicinal components in pediatric pharyngeal flat particles was achieved, and 48 common peaks were established to cover 5 medicinal materials, which improved the efficiency and accuracy of quality control and met the needs of large-scale sample analysis. Ensure the safety and efficacy of the medicine.
Smart Images

Figure CN119064501A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of quality control and evaluation of Chinese patent medicines, and specifically relates to a method for constructing a characteristic spectrum of pediatric pharyngeal flat granules containing in vitro cultured bezoars, and a characteristic spectrum and application thereof. Background Art
[0002] Xiaoer Yanbian Granules (National Medicine Standard Z20055645) are Chinese patent medicines, included in the first part of the "Chinese Pharmacopoeia" (2020 edition), and are composed of eight medicinal materials: honeysuckle, iris, golden fruit olive, platycodon, Scrophularia, Ophiopogon japonicus, artificial bezoar (in vitro cultured bezoar) and borneol. They have the effects of clearing heat and relieving sore throat, detoxification and analgesia. The iris granules produced by Shaanxi Panlong Pharmaceutical Group Co., Ltd. use in vitro cultured bezoar, which has better efficacy. In the prescription, honeysuckle is sweet and cold in nature, enters the lung, stomach, and large intestine meridians, and has the effects of clearing heat and detoxification, dispersing wind and heat, cooling blood and stopping bleeding. Its main active ingredients are chlorogenic acid, isochlorogenic acid C and isochlorogenic acid A; iris is bitter and cold, specifically enters the lung meridian, is good at clearing lung fire, has the effects of clearing heat and detoxification, removing phlegm and relieving sore throat, and is an important medicine for treating sore throat caused by heat toxins and phlegm and fire stagnation. Its main ingredients are iris glycosides and iris flavonoids. Honeysuckle and Belamcanda are used together as the main medicine. Platycodon grandiflorum is the dried root of Platycodon grandiflorum, a plant of the Campanulaceae family. It has a faint smell and a slightly sweet and bitter taste. It has the effects of clearing the lungs and relieving throat, removing phlegm and pus. Its main components are astragaloside and platycodon saponin D. Golden fruit olive is bitter and cold in nature and has the effects of clearing heat and detoxifying, nourishing yin and reducing fire, quenching thirst and promoting body fluid. Its main component is Gulunbin. Scrophularia ningpoensis is bitter, salty and slightly cold. It has the effects of cooling and relieving heat, nourishing yin and reducing fire, and removing toxicity and dispersing nodules. Its main components are aucubin and verbascoside. Ophiopogon japonicus is sweet, slightly bitter and cold, clears the heart and moistens the lungs, clears heat and relieves restlessness, eliminates phlegm and relieves cough. Its main components are methyl ophiopogon flavanone A and methyl ophiopogon homoflavonoid A. The four medicines are matched together to nourish yin and clear the lungs, and are collectively the ministerial medicine. The main active ingredients of Scrophularia are harpagine and harpaoside. Harpagine has multiple biological activities such as anti-inflammatory, antioxidant and immune regulation, while harpaoside further enhances the efficacy of Scrophularia in clearing away heat and detoxification, nourishing yin and reducing fire. The two work together to give Scrophularia significant pharmacological effects; artificial bezoar has the effects of clearing the heart and removing phlegm, opening the mind and refreshing the mind. Its main ingredients are bile acid, hyodeoxycholic acid, etc. Scrophularia and artificial bezoar are used together as adjuvants. In clinical practice, Children's Pharyngeal Granules can be used to treat throat paralysis and tonsils caused by excessive heat in the lungs and stomach in children, with symptoms such as sore throat, cough with excessive phlegm, oral erosion, acute pharyngitis, and acute tonsillitis.
[0003] Currently, there are few quality tests on Pediatric Throat Granules, and most of them are studies on a single ingredient or a single medicinal material in the prescription, which cannot reflect the overall composition of Pediatric Throat Granules. Summary of the invention
[0004] In order to overcome the shortcomings of the above-mentioned prior art, the purpose of the present invention is to provide a method for constructing a characteristic spectrum of pediatric pharyngeal granules containing in vitro cultured bezoar, as well as its characteristic spectrum and application, so as to solve the technical problem that the existing detection methods cannot reflect the overall composition of pediatric pharyngeal granules.
[0005] In order to achieve the above object, the present invention adopts the following technical solutions:
[0006] The first aspect of the present invention discloses a method for constructing a characteristic spectrum of pediatric pharyngeal flat granules containing in vitro cultured bezoar, comprising the following steps:
[0007] S1. The test sample is the Xiaoyanbian granules containing in vitro cultured bezoars;
[0008] S2, using irisin, gulumbin, cryptochlorogenic acid, 3,5-di-O-caffeoylquinic acid, irisin, chlorogenic acid, isochlorogenic acid C, syringin, verbascoside, irisin, rutin, hyperoside, isoverbascoside, angloside C and harpaoside as reference substances;
[0009] S3. Analyze and determine by high performance liquid chromatography to obtain chromatograms of the test solution and the reference solution respectively;
[0010] S4, importing the chromatogram of the test sample solution obtained in S3 into the Chinese medicine chromatographic characteristic spectrum similarity evaluation system and performing similarity analysis to confirm the reliability of the result;
[0011] S5. Determine the chemical composition of each peak in the characteristic spectrum based on the chromatogram of the test solution and the chromatogram of the reference solution obtained in S3, in combination with the total ion current diagram obtained by high-resolution mass spectrometry and the mass spectrum of the chemical components.
[0012] Preferably, in S1, the preparation method of the test solution containing in vitro cultivated bezoar pediatric pharyngeal flat granules is: weigh different batches of powder containing in vitro cultivated bezoar pediatric pharyngeal flat granules respectively, dissolve them in 50% methanol solution, and extract to obtain the test solution containing in vitro cultivated bezoar pediatric pharyngeal flat granules.
[0013] More preferably, in S1, ultrasonic extraction is performed for 45 min.
[0014] Preferably, in S2, the preparation method of the reference solution is: accurately weigh and dissolve irrigated glycosides, gulombin, cryptochlorogenic acid, 3,5-di-O-caffeoylquinic acid, irisin, chlorogenic acid, isochlorogenic acid C, syringin, verbascoside, irisin, rutin, hyperoside, isoverascoside, angloside C and harpaoside to prepare 0.97 mg / mL irrigated glycosides reference solution, 0.89 mg / mL gulombin reference solution, 0.97 mg / mL cryptochlorogenic acid reference solution, and 0.97 mg / mL 3,5-di-O-caffeoylquinic acid reference solution, 0.68 mg / mL irisin reference solution, 0.67 mg / mL chlorogenic acid reference solution, 0.79 mg / mL isochlorogenic acid C reference solution, 0.99 mg / mL syringin reference solution, 0.77 mg / mL verbascoside reference solution, 0.50 mg / mL irisin reference solution, 0.55 mg / mL rutin reference solution, 0.99 mg / mL hyperoside reference solution, 0.69 mg / mL isoverbascoside reference solution, 0.98 mg / mL angoside C reference solution and 0.68 mg / mL harpaoside reference solution.
[0015] More preferably, in S2, 50% methanol solution is used for dissolution.
[0016] Preferably, in S3, the HPLC conditions are: chromatographic column: Shim-pack VP-ODS, 250 mm×4.6 mm, 5 μm chromatographic column; detector: UV-visible absorption detector, detection wavelength is 230 nm; volume flow rate: 1.0 mL / min; injection volume: 10 μL, column temperature is 30°C.
[0017] Further preferably, in S3, acetonitrile is used as mobile phase A, 0.1% phosphoric acid aqueous solution is used as mobile phase C, and the gradient elution program is shown in the following table:
[0018]
[0019] Preferably, in S4, the chromatograms of different batches of pediatric pharyngeal flat granule test solutions obtained in S3 are imported into the traditional Chinese medicine chromatographic characteristic spectrum similarity evaluation system; the chromatographic peaks existing in the chromatograms of different batches of pediatric pharyngeal flat granule test solutions are selected as common peaks, and the control spectrum of pediatric pharyngeal flat granules is generated by the average value calculation method, and the relative retention time and relative peak area of each common peak are calculated; after data import, multi-point correction and data matching, similarity analysis is performed; the similarity result table between the chromatograms of different batches of pediatric pharyngeal flat granule test solutions and the common peak pattern is obtained and exported; the reliability of the result is confirmed based on the similarity result table and the chromatogram of the pediatric pharyngeal flat granule test solution.
[0020] Preferably, in S5, the detection conditions of the high-resolution mass spectrometry are: electrospray ionization, spray voltage 3500V, sheath gas flow rate 40arb, auxiliary gas flow rate 10arb, capillary temperature 300°C, auxiliary gas temperature 300°C, scanning mode is full scan mode, and the mass-to-charge ratio scanning range m / z is 100-1300.
[0021] Further preferably, in S5, high-resolution mass spectrometry is performed on the test solution, the detection data is imported into Xcalibur software, and the Qual Browser interface is entered to perform data analysis according to the peak conditions of the chromatogram to obtain a total ion flow diagram and a mass spectrometry result diagram of each chemical component.
[0022] The second aspect of the present invention discloses the characteristic spectrum of the in vitro cultured bezoar pediatric pharyngeal flat granules obtained by the above construction method.
[0023] The third aspect of the present invention discloses a method for identifying the characteristic spectrum of the in vitro cultured bezoar pediatric pharyngeal flat granules, which is identified by using the characteristic spectrum of the in vitro cultured bezoar pediatric pharyngeal flat granules obtained by the above-mentioned construction method.
[0024] Compared with the prior art, the present invention has the following beneficial effects:
[0025] The present invention provides a method for constructing a characteristic spectrum of pediatric pharyngeal flat granules containing in vitro cultivated bezoars, which adopts a method of high performance liquid chromatography-high resolution mass spectrometry, effectively reflects the position and number of characteristic peaks of pediatric pharyngeal flat granules containing in vitro cultivated bezoars, and realizes the detection of multiple medicinal materials and multiple active ingredients in pediatric pharyngeal flat granules containing in vitro cultivated bezoars (not focusing on a single ingredient or single medicinal material). Compared with the existing method for constructing characteristic spectrum of pediatric pharyngeal flat granules, the characteristic spectrum of pediatric pharyngeal flat granules established by this method has a total of 48 common peaks, and the main 15 characteristic peaks are identified, covering five medicinal materials of honeysuckle, platycodon, Scrophularia, Belamcanda, and Olea europaea, which is helpful for rapid and efficient quality control of pediatric pharyngeal flat granules containing in vitro cultivated bezoars, and controls the ingredients and content of pediatric pharyngeal flat granules as a whole. Through the methodological investigation of the constructed characteristic spectrum method (including precision test, repeatability test and stability test), the similarity values of the results were all higher than 0.99, indicating that the method has good reproducibility and can meet the needs of large-scale sample analysis and testing, providing technical support and theoretical reference for the quality control of pediatric pharyngeal flat granules. The characteristic spectrum of pediatric pharyngeal flat granules containing in vitro cultivated bezoar obtained by this method has a large amount of information, high similarity, good stability, high accuracy, good reproducibility, and high component content. It can comprehensively, accurately, clearly and objectively detect and evaluate the quality of pediatric pharyngeal flat granules containing in vitro cultivated bezoar, which is conducive to more comprehensive and effective control of the quality of its clinical use, better guarantee of safety and efficacy, and make up for the shortcomings of pediatric pharyngeal flat granules containing in vitro cultivated bezoar in component detection. It has an important role and value for the identification of components, quality evaluation, formulation of quality standards and guarantee of clinical efficacy of pediatric pharyngeal flat granules containing in vitro cultivated bezoar.
[0026] Furthermore, in the preparation process of the test solution, 50% methanol solution was used as the extraction solvent, and the extract chromatogram had the most information and the highest component content.
[0027] Furthermore, during the preparation of the test solution, ultrasonic extraction was used, and the chromatogram obtained had comprehensive components and good separation. Ultrasonic extraction for 45 minutes produced a chromatogram with the highest component content, good peak shape, and high separation.
[0028] Furthermore, during the HPLC analysis, when the detection wavelength was 230 nm, the chromatogram contained the most comprehensive information and the baseline was stable. When the column temperature was kept at 30 °C, the peak was the best and the separation effect of each component was better.
[0029] Furthermore, in the process of HPLC analysis, when acetonitrile-0.1% phosphoric acid was used as the mobile phase, the separation effect of the components in the Xiaoer Yanbian granules was better. When elution program 6 was used, the separation was good, the peak height was high, the baseline was stable, and the chromatographic information was complete. BRIEF DESCRIPTION OF THE DRAWINGS
[0030] Figure 1 This is the HPLC characteristic spectrum of Xiaoeryanbian granules containing in vitro cultured bezoar.
[0031] Figure 2 This is a chromatogram obtained by optimizing the extraction method during the preparation of the test solution of the present invention;
[0032] Figure 3 This is a chromatogram obtained by optimizing the extraction solvent during the preparation of the test solution of the present invention;
[0033] Figure 4 This is a chromatogram obtained by optimizing the extraction time during the preparation of the test solution of the present invention;
[0034] Figure 5 The chromatogram obtained by optimizing the detection wavelength under the chromatographic conditions of the present invention;
[0035] Figure 6 The chromatogram obtained by optimizing the column temperature in the chromatographic conditions of the present invention;
[0036] Figure 7 The chromatogram obtained by optimizing the mobile phase composition under the chromatographic conditions of the present invention;
[0037] Figure 8 A chromatogram obtained by optimizing the elution procedure in the chromatographic conditions of the present invention;
[0038] Fig. 9 The chromatogram (A) and mass spectrum (B) of the belamcanda glycosides of the present invention are shown;
[0039] Fig.10 The chromatogram (A) and mass spectrum (B) of Gulumbin of the present invention are shown;
[0040] Fig.11 The chromatogram (A) and mass spectrum (B) of cryptochlorogenic acid of the present invention;
[0041] Fig.12 The chromatogram (A) and mass spectrum (B) of 3,5-di-O-caffeoylquinic acid of the present invention are shown;
[0042] Fig.13 The chromatogram (A) and mass spectrum (B) of irisin of the present invention are shown;
[0043] Fig.14 The chlorogenic acid chromatogram (A) and the chlorogenic acid mass spectrum (B) of the present invention;
[0044] Fig.15 The isochlorogenic acid C chromatogram (A) and isochlorogenic acid C mass spectrum (B) of the present invention;
[0045] Fig.16 The chromatogram (A) and mass spectrum (B) of syringin of the present invention are shown;
[0046] Fig.17 The chromatogram (A) and mass spectrum (B) of verbascoside of the present invention are shown;
[0047] Fig.18 The chromatogram (A) and mass spectrum (B) of irisin of the present invention are shown;
[0048] Fig.19 The rutin chromatogram (A) and rutin mass spectrum (B) of the present invention are shown;
[0049] Fig. 20 The hyperoside chromatogram (A) and the hyperoside mass spectrum (B) of the present invention;
[0050] Fig.21 The chromatogram (A) and mass spectrum (B) of isoverbascoside of the present invention are shown;
[0051] Fig. 22 The chromatogram (A) and mass spectrum (B) of Angoside C of the present invention are shown;
[0052] Fig.23 The chromatogram (A) and mass spectrum (B) of harpaoside of the present invention are shown;
[0053] Fig.24 This is a mass spectrum of the Xiaoeryanbian granules containing in vitro cultured bezoars in the positive ion mode of the present invention;
[0054] Fig.25 This is a mass spectrum of the Xiaoeryanbian granules containing in vitro cultured bezoars in the negative ion mode of the present invention;
[0055] Fig.26 This is the mass spectrum of tectoriusin A / tectoriusin B of the present invention;
[0056] Fig. 27 This is the mass spectrum of platycodon saponin D of the present invention;
[0057] Fig.28 is the mass spectrum of bile acid of the present invention;
[0058] Fig.29 is the mass spectrum of astragaloside of the present invention;
[0059] Fig.30 is the mass spectrum of aucubin of the present invention;
[0060] Fig.31 is the mass spectrum of acteoside of the present invention;
[0061] Fig.32 The mass spectrum of Iris flavescentis of the present invention;
[0062] Fig.33 is the mass spectrum of deoxycholic acid / hyodeoxycholic acid of the present invention;
[0063] Fig.34 is the mass spectrum of harpagine of the present invention;
[0064] Fig.35 is the mass spectrum of caffeic acid of the present invention;
[0065] Fig.36 It is the mass spectrum of 4,5-di-O-caffeoylquinic acid / isochlorogenic acid A / isochlorogenic acid B of the present invention;
[0066] Fig.37 is the mass spectrum of the new chlorogenic acid of the present invention;
[0067] Fig.38 These are characteristic spectra of 15 batches of pediatric pharyngeal flat granules containing in vitro cultured bezoars provided by the present invention. DETAILED DESCRIPTION
[0068] In order to enable those skilled in the art to understand the characteristics and effects of the present invention, the following is a general description and definition of the terms and expressions mentioned in the specification and claims. Unless otherwise specified, all technical and scientific terms used in the text are the common meanings understood by those skilled in the art for the present invention. In the event of a conflict, the definition in this specification shall prevail.
[0069] The theories or mechanisms described and disclosed herein, whether correct or incorrect, should not limit the scope of the present invention in any way, that is, the present invention can be implemented without being limited by any specific theory or mechanism.
[0070] Herein, all features such as values, quantities, contents and concentrations defined in the form of numerical ranges or percentage ranges are for simplicity and convenience only. Accordingly, the description of numerical ranges or percentage ranges should be considered to have included and specifically disclosed all possible secondary ranges and individual values within the range (including integers and fractions).
[0071] In this document, unless otherwise specified, “includes,” “including,” “contains,” “has,” or similar terms cover the meanings of “consisting of” and “mainly consisting of,” for example, “A includes a” covers the meanings of “A includes a and other” and “A only includes a.”
[0072] In this document, in order to make the description concise, not all possible combinations of various technical features in various embodiments or examples are described. Therefore, as long as there is no contradiction in the combination of these technical features, the various technical features in various embodiments or examples can be combined arbitrarily, and all possible combinations should be considered to be within the scope of this specification.
[0073] 1. Construction of feature maps
[0074] A method for constructing a characteristic spectrum of pediatric pharyngeal flat granules containing in vitro cultured bezoars, comprising the following steps:
[0075] S1. Weigh appropriate amounts of different batches of pediatric pharyngeal flat granules containing in vitro cultured bezoars, add 50% methanol solution, and perform ultrasonic extraction for 45 minutes to prepare test solutions of pediatric pharyngeal flat granules containing in vitro cultured bezoars;
[0076] Among them, the method for preparing the test solution of pediatric pharyngeal flat granules containing in vitro cultivated bezoars is preferably: weigh 2.0 g of 15 batches of pediatric pharyngeal flat granules containing in vitro cultivated bezoars respectively, put them in a stoppered conical flask, add 20 mL of 50% methanol solution, ultrasonically extract for 45 minutes, filter, and pass the filtrate through a 0.45 μm microporous filter membrane twice to obtain the test solution of pediatric pharyngeal flat granules containing in vitro cultivated bezoars.
[0077] S2. Weigh iramiside, gulombin, cryptochlorogenic acid, 3,5-di-O-caffeoylquinic acid, irisin, chlorogenic acid, isochlorogenic acid C, syringin, verbascoside, irisin, rutin, hyperoside, isoverbosaside, angloside C and harpaoside respectively, add solvent to dissolve, and obtain a single reference substance solution;
[0078] Among them, the preparation method of the reference solution is preferably: accurately weighing scutellaria glycosides, gulombin, cryptochlorogenic acid, 3,5-di-O-caffeoylquinic acid, irisin, chlorogenic acid, isochlorogenic acid C, syringin, verbascoside, irisin, rutin, hyperoside, isoverbascoside, angloside C and harpaoside, respectively, and dissolving them in 50% methanol solution to prepare a solution containing 0.97 mg of scutellaria glycosides, 0.89 mg of gulombin, 0.97 mg of cryptochlorogenic acid, 0.97 mg of 3,5-di-O-caffeoylquinic acid, 0.68 mg of irisin, 0.67 mg of chlorogenic acid and 0.79 mg of isochlorogenic acid C per 1 mL. A single reference solution of 0.99 mg, syringoside 0.77 mg, irisin 0.50 mg, rutin 0.55 mg, hyperoside 0.99 mg, isovoracoside 0.69 mg, angoside C 0.98 mg and harpaoside 0.68 mg was prepared.
[0079] S3, inject the different batches of the test solution of the Xiaoeryanbian granules containing in vitro cultured bezoar in S1 and the single reference solution in S2 into a high performance liquid chromatograph for chromatographic analysis, perform detection under the same conditions, and record the corresponding chromatograms;
[0080] The liquid chromatography conditions are as follows: chromatographic column: Shim-pack VP-ODS (250 mm × 4.6 mm, 5 μm) chromatographic column; detector: UV-visible absorption detector, detection wavelength is 230 nm; volume flow rate: 1.0 mL / min; injection volume: 10 μL; column temperature: 30° C.; mobile phase: acetonitrile (A)-0.1% phosphoric acid aqueous solution (C), gradient elution, elution program is shown in Table 1:
[0081] Table 1 Liquid chromatography elution program 6
[0082]
[0083] S4. The chromatograms of different batches of pediatric pharyngeal granules containing in vitro cultivated bezoar obtained in S3 are introduced into the Chinese medicine chromatographic characteristic spectrum similarity evaluation system (2004A version); the chromatographic peaks existing in the chromatograms of different batches of pediatric pharyngeal granules containing in vitro cultivated bezoar solution are selected as common peaks, such as Figure 1 As shown; after data import, multi-point correction and data matching, similarity analysis was performed; the similarity result table between the chromatograms of different batches of pediatric pharyngeal granules test solution and the common peak pattern was obtained and exported; the reliability of the results was confirmed based on the similarity result table and the chromatogram of the pediatric pharyngeal granules test solution containing in vitro cultured bezoar.
[0084] S5. Perform high-resolution mass spectrometry analysis on the test solution of the Xiaoeryanbian granules containing in vitro cultured bezoar, import the test data into Xcalibur software, enter the QualBrowser interface, perform data analysis according to the peak conditions of the chemical components, and obtain a total ion flow diagram and a mass spectrum result diagram of the chemical components;
[0085] Among them, the high-resolution mass spectrometry detection conditions are: electrospray ionization, spray voltage 3500V, sheath gas flow rate 40arb, auxiliary gas flow rate 10arb, capillary temperature 300°C, auxiliary gas temperature 300°C, scanning mode is full scan mode, and the mass-to-charge ratio scanning range m / z is 100-1300.
[0086] S6. Based on the chromatogram of the test solution of the pediatric pharyngeal flat granules and the chromatogram of the single reference solution obtained in S3, combined with the total ion flow diagram and the mass spectrum of the chemical components obtained by the high-resolution mass spectrometry in S5, the chemical composition of each peak in the chromatogram of the test sample is determined.
[0087] Taking chlorogenic acid (peak 15) as the reference peak, peak 14 in the chromatogram was identified as syringin, peak 18 as cryptochlorogenic acid, peak 27 as hyperoside, peak 28 as rutin, peak 30 as verbascoside, peak 32 as smilaxoside, peak 33 as isoverbascoside, peak 34 as 3,5-di-O-caffeoylquinic acid, peak 36 as irisin, peak 37 as angoside C, peak 38 as isochlorogenic acid C, peak 42 as harpagoside, peak 43 as gulombin, and peak 48 as irisin. The characteristic spectrum of Xiaoer Yanbian granules was constructed by the method described above.
[0088] 2. Optimization of feature map detection
[0089] This method experimentally investigated the extraction solvent, extraction method, extraction time, mobile phase composition, column temperature and other conditions, optimized the test solution preparation conditions and chromatographic conditions, and thus established a characteristic spectrum detection method for Xiaoer Yanbian granules. The specific steps are as follows:
[0090] S1. Optimization of test solution preparation:
[0091] Through experimental investigation of different extraction methods (ultrasound, reflux, immersion), the results are as follows Figure 2 As shown, it was found that the chromatogram obtained by ultrasonic extraction had relatively comprehensive components and good separation, so the ultrasonic extraction method was adopted;
[0092] By comparing the extraction effects of different extraction solvents (pure acetonitrile solution, 50% acetonitrile solution, 50% methanol solution), the results are as follows Figure 3 As shown, it was found that when 50% methanol solution was used as the extraction solvent, the extract chromatogram had the most information and the highest component content, so 50% methanol solution was selected for extraction;
[0093] By comparing the extraction effects of different extraction times (30min, 45min, 60min), the results are as follows Figure 4 As shown, it was found that the chromatogram obtained when ultrasonic extraction was performed for 45 minutes had the highest component content, good peak shape, and high separation, so 45 minutes was selected as the ultrasonic extraction time.
[0094] S2. Optimize the chromatographic conditions:
[0095] The detection wavelength was investigated by using a UV-visible absorption detector, and the chromatograms at 230nm, 254nm, 275nm, and 290nm were extracted. The results are as follows Figure 5 As shown, it was found that when the detection wavelength condition was 230nm, the chromatogram contained the most comprehensive information and the baseline was stable, so this method was selected as the detection wavelength condition;
[0096] The results were as follows: Figure 6 As shown in the figure, it was found that when the column temperature was kept at 30°C, the peak elution was the best and the separation effect of each component was better, so the column temperature was finally selected to be 30°C;
[0097] By comparing the elution effects of different elution systems such as acetonitrile-0.1% phosphoric acid, methanol-water, methanol-0.1% phosphoric acid, acetonitrile-0.3% phosphoric acid, and acetonitrile-0.4% phosphoric acid under different gradients, the results are as follows Figure 7 As shown, it was found that when acetonitrile-0.1% phosphoric acid was used as the mobile phase, the separation effect of the various components in the pediatric pharyngeal flat granules was better, so acetonitrile-0.1% phosphoric acid was finally selected as the mobile phase.
[0098] After determining the optimal mobile phase composition, a large number of experiments were conducted to screen the best gradient elution program. Some elution programs are shown in Tables 1 to 6. The test results are shown in Figure 8 As shown, it was found that elution program 6 had good separation, high peak height, stable baseline and complete chromatographic information. Therefore, elution program 6 was selected as the optimal elution program.
[0099] Table 2 Elution program 1
[0100]
[0101] Table 3 Elution program 2
[0102]
[0103] Table 4 Elution procedure 3
[0104]
[0105]
[0106] Table 5 Elution Program 4
[0107]
[0108] Table 6 Elution Program 5
[0109]
[0110] The present invention will be further described below in conjunction with specific embodiments. It should be understood that these embodiments are only used to illustrate the present invention and are not intended to limit the scope of the present invention. In addition, it should be understood that after reading the content taught by the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms fall within the scope limited by the appended claims of the application equally.
[0111] The following examples use conventional instruments and equipment in the art. The experimental methods in the following examples without specifying specific conditions are usually carried out under conventional conditions or under conditions recommended by the manufacturer. The various raw materials used in the following examples, unless otherwise specified, are conventional commercial products, and their specifications are conventional specifications in the art.
[0112] In the following examples, some of the instruments used are shown in Table 7; some of the reagents used are shown in Table 8. The different batches of pediatric pharyngeal flat granules samples used were purchased and provided by Shaanxi Panlong Pharmaceutical Group Co., Ltd., and the batch numbers of the 15 batches of drugs were 20201101, 20201102, 20240103, 20240104, 20240105, 20210906, 20210807, 20210808, 20210809, 20210810, 20210811, 20210812, 20210814, 20210303, and 20190505. The reference substances used are: Gulumbin reference substance (batch number: 111837-201703, purity: 99.8%), chlorogenic acid reference substance (batch number: 110753-202119, purity: 96.3%), hyperoside reference substance (batch number: 111521-202310, purity: 94.7%), rutin reference substance (batch number: 100080-202012, purity: 95 %), verbascoside reference substance (batch number: 111530-202315, purity: 97.6%), irisin reference substance (batch number: 110753-202119, purity: 99.4%), syringin reference substance (batch number: 111574-202106, purity: 94.3%), belamcanda glycoside reference substance (batch number: 111632-202304, purity: 98. 7%), harpagoside (batch number: 111730-202110, purity: 96.8%), were purchased from China Food and Drug Inspection Institute; isoverbascoside reference substance (batch number: I115857, purity: 98%), angloside C reference substance (batch number: A110152, purity: 98%), and cryptochlorogenic acid reference substance (batch number: C117944, purity: 99%) were all purchased from Shanghai Aladdin Biochemical Technology Co., Ltd.; irisin reference substance (batch number: CN010229, purity: 98%), isochlorogenic acid C reference substance (batch number: CN000648, purity: 98.5%) were purchased from Chengdu Pusi Biotechnology Co., Ltd.; 3,5-di-O-caffeoylquinic acid reference substance (batch number: SD8900, purity: ≥98%) was purchased from Beijing Solebow Technology Co., Ltd.
[0113] Table 7 Instruments
[0114]
[0115] Table 8 Reagents
[0116]
[0117] Example 1
[0118] The method for constructing the characteristic spectrum of pediatric pharyngeal flat granules comprises the following steps:
[0119] S1. Preparation of test solution of children's pharyngeal flat granules:
[0120] Weigh 2.0 g of 15 batches of pediatric pharyngeal flat granules containing in vitro cultured bezoars, put them into a stoppered conical flask, add 20 mL of 50% methanol solution, ultrasonically extract for 45 min, filter, and pass the filtrate through a 0.45 μm microporous filter membrane twice to obtain 15 batches of pediatric pharyngeal flat granule test solutions.
[0121] S2. Preparation of reference solution:
[0122] Precisely weighed scutellarin, gulombin, cryptochlorogenic acid, 3,5-di-O-caffeoylquinic acid, irisin, chlorogenic acid, isochlorogenic acid C, syringin, verbascoside, irisin, rutin, hyperoside, isoverbascoside, angloside C and harpaoside and dissolved them in 50% methanol solution to prepare 0.97 mg scutellarin, 0.89 mg gulombin, 0.97 mg cryptochlorogenic acid, 0.97 mg 3,5-di-O-caffeoylquinic acid, 0.68 mg irisin, 0.67 mg chlorogenic acid and 0.79 mg isochlorogenic acid C per 1 mL. A single reference solution of 0.50 mg, 0.55 mg, 0.99 mg of syringoside, 0.77 mg of verbascoside, 0.50 mg of irisin, 0.55 mg of rutin, 0.99 mg of hyperoside, 0.69 mg of isovorascoside, 0.68 mg of angoside C and 0.68 mg of harpaoside was prepared.
[0123] S3. Inject the test solutions of 15 batches of pediatric pharyngeal flat granules containing in vitro cultivated bezoar in S1 and the single reference solution in S2 into high performance liquid chromatography for chromatographic analysis, and perform detection under the same conditions. The liquid chromatography conditions are as follows: chromatographic column: Shim-pack VP-ODS (250mm×4.6mm, 5μm) chromatographic column; detector: UV-visible absorption detector, detection wavelength is 230nm; volume flow rate: 1.0mL / min; injection volume: 10μL; column temperature: 30℃; mobile phase: acetonitrile (A)-0.1% phosphoric acid aqueous solution (C), gradient elution, the elution program is shown in Table 1, and record the corresponding chromatogram.
[0124] The chromatogram of the test solution of Xiaoer Yanbian Granule containing in vitro cultured bezoar is as follows Figure 1 The chromatogram of a single reference solution is shown in Figure 9 to Figure 23shown.
[0125] S4. Import the chromatograms of 15 batches of test solutions of Children's Throat Bian Granules containing in vitro cultivated bezoars obtained in S3 into the Traditional Chinese Medicine Chromatographic Characteristic Spectrum Similarity Evaluation System (2004A Version); select the chromatographic peaks existing in the chromatograms of different batches of test solutions of Children's Throat Bian Granules containing in vitro cultivated bezoars as common peaks, generate a control spectrum of Children's Throat Bian Granules containing in vitro cultivated bezoars by the average value calculation method, and calculate the relative retention time and relative peak area of each common peak; perform similarity analysis after data import, multi-point correction and data matching; obtain and export the similarity result table between the chromatograms of different batches of test solutions of Children's Throat Bian Granules containing in vitro cultivated bezoars and the common peak pattern; confirm the reliability of the result based on the similarity result table and the chromatogram of the test solution of Children's Throat Bian Granules containing in vitro cultivated bezoars.
[0126] S5. The test solution of Xiaoer Yanbian Granule containing in vitro cultured bezoar was analyzed by high-resolution mass spectrometry. The detection conditions of high-resolution mass spectrometry were: electrospray ionization, spray voltage 3500V, sheath gas flow rate 40arb, auxiliary gas flow rate 10arb, capillary temperature 300℃, auxiliary gas temperature 300℃, full scan mode, mass-to-charge ratio scanning range m / z 100-1300. The detection data was imported into Xcalibur software, entered into the Qual Browser interface, and data analysis was performed according to the peak conditions of chemical components to obtain the total ion flow diagram ( Fig.24 and Fig.25 ) and the mass spectrometry results of chemical components ( Figure 26 to Figure 37 ), and the attribution analysis of 31 chemical components was carried out, among which 3,5-di-O-caffeoylquinic acid, 4,5-di-O-caffeoylquinic acid, isochlorogenic acid A, isochlorogenic acid B, isochlorogenic acid C, neochlorogenic acid, cryptochlorogenic acid, caffeic acid, chlorogenic acid, rutin and hyperoside were derived from honeysuckle; tectoriusin A, tectoriusin B, tectoriusin, tectoriusin, belamcandarin and tectoriusin were derived from belamcanda; aucubin, acteoside, verbascoside, isovorascoside, angoside C, harpaoside and harpacoside were derived from Scrophularia ningpoensis; baicalin, platycoside D and syringin were derived from Platycodon grandiflorum; cholic acid, deoxycholic acid and hyodeoxycholic acid were derived from bezoar; and gulunbin was derived from Olea europaea.
[0127] S6. Based on the chromatogram of the test solution of the Children's Yanbian Granules containing in vitro cultivated bezoars and the chromatogram of the single reference solution obtained in S3, combined with the total ion flow diagram obtained by high-resolution mass spectrometry and the mass spectrum result diagram of the chemical components, a comparison was performed. Combined with the HPLC-MS component analysis results of the extracts of 8 medicinal materials in the preparation prescription, including honeysuckle, belamcanda, golden fruit olive, platycodon, figwort, ophiopogon, bezoar, and borneol, the chemical components corresponding to the 15 characteristic peaks in the characteristic spectrum of the Children's Yanbian Granules were attributed and analyzed. Among them, chlorogenic acid (peak 15), cryptochlorogenic acid (peak 23), and chlorogenic acid (peak 30) were found to be the most abundant. (Peak 18), hyperoside (Peak 27), rutin (Peak 28), 3,5-di-O-caffeoylquinic acid (Peak 34), and isochlorogenic acid C (Peak 38) are derived from honeysuckle; syringoside (Peak 14) is derived from Platycodon grandiflorum; verbascoside (Peak 30), isoverbascoside (Peak 33), angloside C (Peak 37), and harpaoside (Peak 42) are derived from Scrophularia ningpoensis; belamcandaside (Peak 32), irisin (Peak 36), and irisin (Peak 48) are derived from Belamcanda chinensis; and gulubine (Peak 43) is derived from Olea europaea.
[0128] Taking chlorogenic acid (peak 15) as the reference peak, peak 14 in the chromatogram is syringin, peak 18 is cryptochlorogenic acid, peak 27 is hyperoside, peak 28 is rutin, peak 30 is verbascoside, peak 32 is belamcandaside, peak 33 is isoverbascoside, peak 34 is 3,5-di-O-caffeoylquinic acid, peak 36 is irisin, peak 37 is angoside C, peak 38 isochlorogenic acid C, peak 42 is harpagoside, peak 43 is gulombin, peak 48 is irisin, and the characteristic spectrum of Xiaoer Yanbian granules is obtained ( Fig.38 ).
[0129] At the same time, the automatically generated reference spectrum R was used to generate the common chromatographic peak pattern, and the analysis and calculation showed that the common chromatographic peaks of the 15 batches of pediatric pharyngeal flat granules tested had relatively good similarity. The results are shown in Table 9. The results indicate that the characteristic spectrum of pediatric pharyngeal flat granules containing in vitro cultivated bezoar established by this method can well detect the quality of pediatric pharyngeal flat granules containing in vitro cultivated bezoar and 15 batches of pediatric pharyngeal flat granules containing in vitro cultivated bezoar.
[0130] Table 9 Similarity between each batch of samples and the common chromatographic peak pattern
[0131]
[0132]
[0133] Example 2
[0134] Methodological research on characteristic spectrum detection method:
[0135] S1. Precision study
[0136] The test solution prepared by the method of Example 1 was taken and analyzed according to the detection method of Example 1. The samples were injected in parallel 6 times with an injection volume of 10 μL. Belamcanda glycosides, Gulumbin, cryptochlorogenic acid, 3,5-di-O-caffeoylquinic acid, irisin, chlorogenic acid, isochlorogenic acid C, syringin, verbascoside, irisin, rutin, hyperoside, isoverbascoside, angloside C, and harpagoside were used as reference peaks. The peak areas and retention times were analyzed and the RSD values were calculated. The results showed that the RSDs of the relative retention times were less than 0.15%, and the RSDs of the relative peak areas were less than 1.90%, indicating that the parallel injection precision of the equipment was good.
[0137] S2. Stability study
[0138] The test solution prepared by the method of Example 1 was taken and analyzed according to the detection method of Example 1. The sample was injected and analyzed at different times of 0, 2, 6, 12, 18, and 24 h, and the injection volume was 10 μL. Belamcanda glycosides, Gulumbin, cryptochlorogenic acid, 3,5-di-O-caffeoylquinic acid, irisin, chlorogenic acid, isochlorogenic acid C, syringin, verbascoside, irisin, rutin, hyperoside, isoverascoside, angloside C, and harpagoside were used as reference peaks. The peak area and retention time of the common peaks of the HPLC characteristic spectrum of the sample were analyzed and the RSD value was calculated. The results showed that the RSD of the relative retention time was less than 0.14%, and the RSD of the relative peak area was less than 2.10%, indicating that the chromatographic peak of the test solution of the pediatric pharyngeal flat granules within 24 h had almost no change and good stability.
[0139] S3. Reproducibility study
[0140] Six batches of sample solutions were prepared according to the test solution method in Example 1, with reference to the chromatographic conditions of Example 1, the injection volume was 10 μL, and scutellaria glycosides, gulombin, cryptochlorogenic acid, 3,5-di-O-caffeoylquinic acid, irisin, chlorogenic acid, isochlorogenic acid C, syringin, verbascoside, irisin, rutin, hyperoside, isoverascoside, angloside C, and harpagoside were used as reference peaks. The peak area and retention time of the common peaks of the HPLC characteristic spectrum of the samples were analyzed and the RSD values were calculated. The results showed that the RSD of the relative retention time was less than 0.17%, and the RSD of the relative peak area was less than 2.40%, indicating that the sample chromatographic peaks had good reproducibility and the method had good repeatability.
[0141] The above experimental results indicate that the characteristic spectrum construction method for pediatric pharyngeal flat granules containing in vitro cultivated bezoars provided by the present invention has the characteristics of good stability, high precision and good repeatability, and can comprehensively and objectively evaluate the quality of pediatric pharyngeal flat granules containing in vitro cultivated bezoars, providing quality assurance for clinical efficacy.
[0142] The above contents are only for explaining the technical idea of the present invention and cannot be used to limit the protection scope of the present invention. Any changes made on the basis of the technical solution in accordance with the technical idea proposed by the present invention shall fall within the protection scope of the claims of the present invention.
Claims
1. A method for constructing a characteristic spectrum of children's pharyngeal flat granules containing in vitro cultured bezoar, characterized in that: The following steps are involved: S1. The test sample is the Xiaoyanbian granules containing in vitro cultured bezoars; S2, using irisin, gulumbin, cryptochlorogenic acid, 3,5-di-O-caffeoylquinic acid, irisin, chlorogenic acid, isochlorogenic acid C, syringin, verbascoside, irisin, rutin, hyperoside, isoverbascoside, angloside C and harpaoside as reference substances; S3. Analyze and determine by high performance liquid chromatography to obtain chromatograms of the test solution and the reference solution respectively; S4, importing the chromatogram of the test sample solution obtained in S3 into the Chinese medicine chromatographic characteristic spectrum similarity evaluation system and performing similarity analysis to confirm the reliability of the result; S5. Determine the chemical composition of each peak in the characteristic spectrum based on the chromatogram of the test solution and the chromatogram of the reference solution obtained in S3, in combination with the total ion current diagram obtained by high-resolution mass spectrometry and the mass spectrum of the chemical components.
2. The method for constructing a characteristic spectrum of the Xiaoer Yanbian granules containing in vitro cultured bezoar according to claim 1, characterized in that: In S1, the preparation method of the test solution containing in vitro cultivated bezoar pediatric pharyngeal flat granules is: weigh different batches of powder containing in vitro cultivated bezoar pediatric pharyngeal flat granules respectively, dissolve them in 50% methanol solution, and extract to obtain the test solution containing in vitro cultivated bezoar pediatric pharyngeal flat granules.
3. The method for constructing a characteristic spectrum of the children's pharyngeal flat granules containing in vitro cultured bezoar according to claim 2, characterized in that: In S1, ultrasonic extraction was used for 45 min.
4. The method for constructing a characteristic spectrum of the Xiaoer Yanbian granules containing in vitro cultured bezoar according to claim 1, characterized in that: In S2, the preparation method of the reference solution is as follows: accurately weigh and dissolve irrigated glycosides, gulombin, cryptochlorogenic acid, 3,5-di-O-caffeoylquinic acid, irisin, chlorogenic acid, isochlorogenic acid C, syringin, verbascoside, irisin, rutin, hyperoside, isoverbascoside, angloside C and harpaoside to prepare 0.97 mg / mL irrigated glycosides reference solution, 0.89 mg / mL gulombin reference solution, 0.97 mg / mL cryptochlorogenic acid reference solution and 0.97 mg / mL 3,5-di-O-caffeoylquinic acid reference solution, 0.68 mg / mL irisin reference solution, 0.67 mg / mL chlorogenic acid reference solution, 0.79 mg / mL isochlorogenic acid C reference solution, 0.99 mg / mL syringin reference solution, 0.77 mg / mL verbascoside reference solution, 0.50 mg / mL irisin reference solution, 0.55 mg / mL rutin reference solution, 0.99 mg / mL hyperoside reference solution, 0.69 mg / mL isoverbascoside reference solution, 0.98 mg / mL angoside C reference solution and 0.68 mg / mL harpaoside reference solution.
5. The method for constructing a characteristic spectrum of the Xiaoer Yanbian granules containing in vitro cultured bezoar according to claim 4, characterized in that: In S2, 50% methanol solution was used for dissolution.
6. The method for constructing a characteristic spectrum of the Xiaoer Yanbian granules containing in vitro cultured bezoar according to any one of claims 1 to 5, characterized in that: In S3, the HPLC conditions were as follows: chromatographic column: Shim-pack VP-ODS, 250 mm × 4.6 mm, 5 μm chromatographic column; detector: UV-visible absorption detector, detection wavelength was 230 nm; volume flow rate: 1.0 mL / min; injection volume: 10 μL, column temperature was 30°C.
7. The method for constructing a characteristic spectrum of the Xiaoer Yanbian granules containing in vitro cultured bezoar according to claim 6, characterized in that: In S3, acetonitrile was used as mobile phase A, 0.1% phosphoric acid aqueous solution was used as mobile phase C, and the gradient elution program was as shown in the following table:
8. The method for constructing a characteristic spectrum of the Xiaoer Yanbian granules containing in vitro cultured bezoar according to any one of claims 1 to 5, characterized in that: In S5, the detection conditions of high-resolution mass spectrometry are: electrospray ionization, spray voltage 3500 V, sheath gas flow rate 40 arb, auxiliary gas flow rate 10 arb, capillary temperature 300°C, auxiliary gas temperature 300°C, scanning mode is full scan mode, and the mass-to-charge ratio scanning range m / z is 100-1300.
9. The characteristic spectrum of in vitro cultured Niuhuang Xiaoer Yanbian granules obtained by the construction method according to any one of claims 1 to 8.
10. A method for identifying characteristic patterns of in vitro cultured Niuhuang Xiaoer Yanbian granules, characterized in that: The identification is performed using the characteristic spectrum of the in vitro cultured bezoar pediatric pharyngeal flat granules obtained by the construction method described in any one of claims 1 to 8.
Citation Information
Cited By
Quality detection method of infantile pharyngeal flat granules
CN119688882A
Construction method of fingerprint spectrum of Shenkun blood-nourishing granules and fingerprint spectrum of Shenkun blood-nourishing granules
CN119936250A
Gusongbao tablet fingerprint spectrum construction method, and fingerprint spectrum and application of Gusongbao tablet fingerprint spectrum
CN120908368A
